CGS 12066B
Latest Information Update: 24 Jan 1996
At a glance
- Originator Novartis
- Class Anxiolytics
- Mechanism of Action 5-HT1A serotonin receptor agonists; Serotonin 1B receptor agonists; Serotonin 5-HT2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 10 Nov 1995 New profile
- 10 Nov 1995 Discontinued-Preclinical for Anxiety disorders in Switzerland (Unknown route)